Woman Care Global to Bring Affordable Emergency Contraception to Women Across the United States

WomanCare Global Sustainable Healthcare Logo

SAN DIEGO, July 28, 2014 (GLOBE NEWSWIRE) -- Woman Care Global (WCG) has just announced that it will bring affordable emergency contraception to women across the United States.

In conjunction with partners HPSRx and Novel Laboratories, WCG will market Levonorgestrel 1.5 mg Emergency Contraceptive (EC) tablet, containing the same active ingredient as Plan B One-Step®, to private medical practices across the US. The Levonorgestrel 1.5 mg EC tablet, manufactured in the US, is available over-the-counter without a prescription. It is anticipated that Levonorgestrel 1.5 mg EC tablet will provide a significant cost advantage to users.

"We are committed to women in the United States and are thrilled to create access to an important cost effective generic product like Levonorgestrel 1.5 mg EC tablet," said Saundra Pelletier, CEO of Woman Care Global. "All women, no matter where they live, should have access to safe and affordable products so that they are in full control of their reproductive health at all times. Emergency contraception is a vital option that provides protection when the unexpected happens."

About WomanCare Global

Woman Care Global is a global non-profit healthcare company focused on women's reproductive health. Meeting the vast unmet demand for family planning and enabling women to choose whether and when they'll have children requires investing in cost-effective, innovative approaches. Woman Care Global's mission is to provide access to reproductive health solutions for women and girls around the world. Leveraging our medical, social and commercial expertise, we have built a sustainable value chain that enables us to reliably deliver high-quality products and point of care services, resulting in more informed providers and more family planning options for women and girls. Our hybrid model redirects financial surplus achieved from sales in developed countries to under-served markets thereby eliminating economic and geographic barriers and increasing impact. For more information, please visit womancareglobal.org.

About Levonorgestrel 1.5 mg Emergency Contraceptive (EC) Tablet

Levonorgestrel 1.5 mg is intended to prevent pregnancy after known or suspected contraceptive failure or unprotected intercourse. Levonorgestrel 1.5 mg should be taken as soon as possible within 72 hours (3 days) of unprotected sex. Levonorgestrel 1.5 mg is not effective if you are already pregnant and will not terminate an existing pregnancy. Levonorgestrel 1.5 mg does not protect against HIV and other sexually transmitted infections (STIs). Side effects may include changes in your period, nausea, lower abdominal pain, fatigue, headache and dizziness. If your period is more than a week late, you may be pregnant. You should not take Levonorgestrel 1.5 mg if you are already pregnant. Levonorgestrel 1.5 mg should not be used as a routine birth control method, as it is not as effective. If you have severe abdominal pain, you many have an ectopic pregnancy and should get immediate medical help. You are encouraged to report negative side effects of prescription drugs to the FDA at fda.gov/medwatch or call 1-800-FDA-1088.

Media Inquiries
Ellen Thomas

CONTACT: Media Inquiries Ellen Thomas +1.718.490.3248 ethomas@womancareglobal.org

Source: WomanCare Global